net dbt
margin expans stand-out
revenu line bofaml con
non-gaap npat ahead expect bofaml
con gross margin expans oper leverag
point strong mask growth row result
brightre resuppli program new mask launch ii solid us devic
sale howev row devic sale slow franc japan
complet upgrad cycl iii matrixcar contribut half gross
margin expans balanc compris procur manufactur mix iv
oper leverag fx tailwind led lower sg cost saa
revenu doubl pcp follow acquisit matrixcar matrixcar deliv doubl
saa copd set growth
reiter buy given success launch mask rang
belief saa strategi benefit long term rais po
per share previous reflect today result key chang gross
margin uplift onward invest onward
futur growth saa come focu brightre achiev doubl digit growth
via modul expans attract new user price increas ii revenu synergi
fine-tun digit health capabl across brightre matrixcar
healthcarefirst iii leverag sleep data expans outsid us agenda
earli stage copd chronic obstruct pulmonari diseas strategi
propel acquisit mobi launch access potenti client base via saa
set foundat penetr market across stage copd
full definit iqmethod sm measur see page
employ non-u affili mlpf registered/qualifi research analyst
finra rule
refer import disclosur inform certain bofa merril lynch entiti take
respons inform herein particular jurisdict
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
outsid equiti interest npat
chang work capit
 flow item int tax
 flow oper
oper
acquisit dispos invest
 flow invest
invest
 flow financ
financ
return capit employ
return equiti
iqmethod sm qualiti earn
full definit iqmethod sm measur see page
lead develop
manufactur medic devic mask cloud-
base softwar applic diagnos treat
manag respiratori disord headquart
san diego california focuss
connect health deliv better outcom
sleep apnea chronic obstruct pulmonari
outpac industri growth
market share place
everi market oper benefit
clinic data-captur proprietari
softwar boost therapi complianc
rate increas mask accessori growth
addit market develop
market activ target
moder sever osa suffer world-wide
price book valu
loss attribut equiti method invest
 revenue
sg revenue
 revenue
sg revenue
price object per share base dcf
valuat dcf use wacc termin growth rate beta
downsid risk po loss momentum saa busi market
educ effort achiev expect revenu growth reimburs
chang health ministri phi poor recept new product launch
technolog advanc competitor product fx chang
lyann harrison herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
